Perspectives and insights regarding regulatory considerations when planning and conducting immunotherapy studies.
David Li, MD, PhD
Advertisement
Articles by David Li, MD, PhD
Advertisement
Latest Updated Articles
- Initial Design Considerations for Immuno-Oncology Trials
Published: August 13th 2020 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Praxis Reports Positive Phase III Results for Ulixacaltamide in Essential Tremor
2
Setting the Limits of Autonomy with Autonomous Agents for Clinical Research
3
Adaptive Trial Design as a Pathway to Faster Development
4
Eli Lilly’s Orforglipron Shows Superior Efficacy Across Multiple Phase III Trials in Type 2 Diabetes
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
